|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Enlivex Therapeutics (NASDAQ: ENLV) through any online brokerage.
There are no as such competitors for Enlivex Therapeutics.
The latest price target for Enlivex Therapeutics (NASDAQ: ENLV) was reported by HC Wainwright & Co. on January 9, 2020. The analyst firm set a price target for 20.00 expecting ENLV to rise to within 12 months (a possible 112.77% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Enlivex Therapeutics (NASDAQ: ENLV) is $9.4 last updated Thu Jun 17 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Enlivex Therapeutics.
Enlivex Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Enlivex Therapeutics.
Enlivex Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.